Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 21, 2014; 20(23): 7452-7460
Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7452
Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7452
Figure 2 Transforming growth factor β1 and platelet-derived growth factor mRNA expression was assessed by polymerase chain reaction analysis.
A: Transforming growth factor β1 (TGFβ1); B: Platelet-derived growth factor (PDGF). BDL: Bile duct ligation; Rapa: Rapamycin; Rapa+: Rat administered rapamycin for 28 d starting the 14th day after BDL; Rapa++: Rat administered rapamycin treatment for 28 d starting the 1st day after BDL; GAPDH: Glyceraldehyde 3-phosphate dehydrogenase. aP < 0.05 vs other group; cP < 0.05 vs BDL+/Rapa++ group.
- Citation: Kim YJ, Lee ES, Kim SH, Lee HY, Noh SM, Kang DY, Lee BS. Inhibitory effects of rapamycin on the different stages of hepatic fibrosis. World J Gastroenterol 2014; 20(23): 7452-7460
- URL: https://www.wjgnet.com/1007-9327/full/v20/i23/7452.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i23.7452